4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Market Cap $62.57M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Coventry Group Limited
| Forum | Tag | Subject | View | Poster | |||||
|---|---|---|---|---|---|---|---|---|---|
| ASX - By Stock | CYG | Ann: Change in substantial holding | Thread |
 ASX News
|
0 | 69 | 0 | 18/04/18 | |
|
|||||||||
| ASX - By Stock | CYG | Ann: Q3 2018 Trading update | Thread |
ASX News
|
0 | 100 | 0 | 13/04/18 | |
|
|||||||||
| ASX - By Stock | CYG | Ann: Change of Director's Interest Notice | Thread |
ASX News
|
0 | 99 | 0 | 16/03/18 | |
|
|||||||||
| ASX - By Stock | CYG | Ann: Change of Director's Interest Notice | Thread |
ASX News
|
0 | 107 | 0 | 07/03/18 | |
|
|||||||||
